Insulet
PODD
$174.43
Share price
0.58%
Change (1 day)
-45.66%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Total assets
Total assets on the balance sheet as of December 2023 : $2.58 B
According to Insulet's latest financial reports the company's total assets are $2.58 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Insulet - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $2.58 B | 14.97% |
| 2022-12-31 | $2.25 B | 9.87% |
| 2021-12-31 | $2.04 B | 9.39% |
| 2020-12-31 | $1.87 B | 63.87% |
| 2019-12-31 | $1.14 B | 23.06% |
| 2018-12-31 | $0.92 B | 13.71% |
| 2017-12-31 | $0.81 B | 78.86% |
| 2016-12-31 | $0.45 B | 65.98% |
| 2015-12-31 | $0.27 B | -7.42% |
| 2014-12-31 | $0.29 B | 3.2% |
| 2013-12-31 | $0.28 B | 45.39% |
| 2012-12-31 | $0.19 B | -10.51% |
| 2011-12-31 | $0.22 B | 41.66% |
| 2010-12-31 | $0.15 B | -8.98% |
| 2009-12-31 | $0.17 B | 58.59% |
| 2008-12-31 | $0.10 B | -17.22% |
| 2007-12-31 | $0.13 B | 128.81% |
| 2006-12-31 | $57.14 M | 240.28% |
| 2005-12-31 | $16.79 M | -38.08% |
| 2004-12-31 | $27.12 M | 447.01% |
| 2003-12-31 | $4.95 M | -71.69% |
| 2002-12-31 | $17.51 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 6,373.92% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | 2,728.76% | 🇺🇸 USA |
 Medtronic MDT | $90.83 B | 3,409.62% | 🇮🇪 Ireland |
 Eli Lilly LLY | $64.00 B | 2,373.00% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.95 B | -63.19% | 🇺🇸 USA |
 ICU Medical
ICUI | $4.37 B | 69.17% | 🇺🇸 USA |
 DexCom DXCM | $6.48 B | 150.45% | 🇺🇸 USA |